FdaApplication
ANDA 218271
Identifiers
- fda_app_no: ANDA218271
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2025-03-11 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | 50MG/10ML (5MG/ML) | SOLUTION;INTRAVENOUS |
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | 25MG/5ML (5MG/ML) | SOLUTION;INTRAVENOUS |
2 products